Cargando…

Diagnosis and management of chronic obstructive pulmonary disease in Serbia: an expert group position statement

In recent years, several national chronic obstructive pulmonary disease (COPD) guidelines have been issued. In Serbia, the burden of COPD is high and most of the patients are diagnosed at late stages. Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy is poorly implemented in rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Vukoja, Marija, Kopitovic, Ivan, Lazic, Zorica, Milenkovic, Branislava, Stankovic, Ivana, Zvezdin, Biljana, Dudvarski Ilic, Aleksandra, Cekerevac, Ivan, Vukcevic, Miodrag, Zugic, Vladimir, Hromis, Sanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6730542/
https://www.ncbi.nlm.nih.gov/pubmed/31564847
http://dx.doi.org/10.2147/COPD.S214690
Descripción
Sumario:In recent years, several national chronic obstructive pulmonary disease (COPD) guidelines have been issued. In Serbia, the burden of COPD is high and most of the patients are diagnosed at late stages. Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy is poorly implemented in real-life practice, as many patients are still prescribed inhaled corticosteroids (ICS)-containing regimens and slow-release theophylline. In this document, we propose an algorithm for treating COPD patients in Serbia based on national experts’ opinion, taking into account global recommendations and recent findings from clinical trials that are tailored according to local needs. We identified four major components of COPD treatment based on country specifics: active case finding and early diagnosis in high-risk population, therapeutic algorithm for initiation and escalation of therapy that is simple and easy to use in real-life practice, de-escalation of ICS in low-risk non-exacerbators, and individual choice of inhaler device based on patients' ability and preferences. With this approach we aim to facilitate implementation of the recommendation, initiate the treatment in early stages, improve cost-effectiveness, reduce possible side effects, and ensure efficient treatment.